BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bolton Medical Announces Completion of the Patient Enrollment Phase of the U.S. RELAY Thoracic Stent-Graft Clinical Trial


5/5/2010 12:38:57 PM

SUNRISE, FL--(Marketwire - May 05, 2010) - Bolton Medical announced today that patient enrollment in the U.S. Clinical Trial to evaluate the RELAY Thoracic Stent-Graft for the treatment of thoracic aortic aneurysms has concluded. The study included 120 endovascular patients at 30 hospitals across the country.

The device is already approved for use in Europe and international markets, and to date, more than 3000 RELAY Thoracic Stent-Grafts have been implanted worldwide.

"Completing enrollment is an exciting step in the study," states National Principal Investigator and Associate Professor of Surgery and Radiology, University of North Carolina, Chapel Hill, NC, Dr. Mark Farber. "We expect to see excellent results in the patient follow-up data and anticipate the device to be approved for sale in the U.S. in 2011."

The RELAY Thoracic Stent-Graft system has the longest device length options (from 90-250mm). The system is also available in a wide range of diameters (from 22-46mm) including smaller caliber sizes which allow for repair of patients with smaller diameter aortas. In addition, the device features a unique delivery system that allows for excellent proximal conformability and controlled deployment.

During an actual procedure, the RELAY Thoracic Stent-Graft is placed inside the diseased aorta without a major surgical incision and seals off the aneurysm allowing normal blood flow to resume. Because it was designed specifically for the thoracic anatomy, it allows surgeons to achieve placement in difficult, curved or otherwise challenging parts of a patient's unique anatomy.

Thoracic Stent-Grafts are an alternative to traditional open surgery for patients requiring treatment for main thoracic pathologies. The endovascular stent-graft procedure generally results in a reduced hospital stay and a shorter recovery time for the patient.

COMPANY
Bolton Medical is a private company, with European operations based in Barcelona, Spain, and U.S. operations in Sunrise, Florida. Bolton Medical is a wholly-owned subsidiary of the Werfen Life Group, a diverse manufacturer and supplier of products for the medical industry.
www.boltonmedical.com


Public Relations Contacts:
USA:
Candace DeLeonardis
1-954-636-9785

EU and other countries:
Carlos Camps
+ 34 93.817.63.10



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES